Portfoliotracker

Henry Schein, Inc.: výsledky za 4. čtvrtletí 2026

Zveřejněno 3. 11. 2026, před otevřením burzy. Zisk na akcii 1,37 $ proti odhadu 1,36.

Karta firmy

AI shrnutí

AI
Objednat AI shrnutí těchto výsledků Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně. Minule se to nepodařilo, zkus to znovu.

Shrnutí ukáže, jak výsledky dopadly, co firma splnila, výhody a nevýhody a proč akcie zareagovala tak, jak zareagovala.

Tisková zpráva firmy

Otevřít na SEC

Přepis telefonního hovoru s analytiky je chráněný autorským právem, proto tady ukazujeme veřejnou tiskovou zprávu.

Zobrazit celý text (anglicky)
EX-99.1
2
exhibit991.htm
EX-99.1

-1-

more

FOR IMMEDIATE RELEASE

HENRY SCHEIN REPORTS STRONG 2026 THIRD QUARTER AND RAISES FY2026 GUIDANCE

●

Q3 2026 GAAP diluted EPS of $1.06, up 26.2% versus prior year;

Q3 2026 non-GAAP diluted EPS of $1.56,

up 13.0% versus prior year

●

4.0% total sales growth, driven by 8.6% U.S. dental merchandise sales growth due primarily to volume

from

market share gains

●

Raises FY2026 guidance for non-GAAP diluted EPS

(A)

to $5.50 to $5.56 and Adjusted EBITDA growth to

high-single-digits reflecting strong operating performance,

net tariff refund benefits, and targeted, limited

growth-investments

MELVILLE, N.Y.,

November 3, 2026 –

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare

solutions to office-based dental and medical practitioners, today reported financial results

for the third quarter ended

September 26, 2026. The Company reported $3.5 billion in sales with

total growth of 4.0%,

and 3.1% internally in local

currencies. GAAP earnings per share grew 26.2% versus the prior year. Non-GAAP earnings per share grew 13.0%,

or

19.1% when excluding current-quarter net tariff refunds and the prior-year

remeasurement gains (refer to Exhibit D).

“We delivered another strong quarter that increases our confidence in the momentum we are building at Henry

Schein. I am very pleased with the U.S. dental merchandise sales

growth of 8.6% driven primarily by volume in a stable

market and our 19%

adjusted earnings per share growth

4

,” said Fred Lowery, Chief Executive Officer of Henry Schein.

“Our strategy is translating into stronger financial results. We are gaining share in key businesses, improving our portfolio

mix,

maintaining a disciplined approach to capital allocation, and realizing

the benefits of our value creation initiatives,”

Mr. Lowery added.

Third Quarter 2026

Financial Results

●

Total

net sales

for the quarter were $3.5 billion,

an increase of 4.0% in total compared to the third quarter of

2025, reflecting 3.1% internal sales growth, 0.7% sales growth from

acquisitions, and a 0.2% increase resulting

from foreign currency exchange. Third quarter sales growth is

detailed in Exhibit A

1

.

●

Global Distribution and Value-Added Services sales

for the quarter increased 3.7% in total, reflecting 2.9%

internal sales growth, 0.5% sales growth from acquisitions, and

a 0.3% increase from foreign currency exchange

compared with the third quarter of 2025. The main components compared

with the third quarter of 2025 are:

●

Global Dental Distribution merchandise sales

for the quarter increased 7.0% in total, and by 5.1%

internal sales growth, compared with the third quarter of 2025.

-2-

more

●

Global Dental Distribution equipment sales

for the quarter increased 2.3% in total,

and by 2.4%

internal sales growth, compared with the third quarter of 2025.

●

Global Medical Distribution sales

for the quarter increased 1.1% in total, and by 1.0% internal

sales

growth, compared with the third quarter of 2025.

●

Global Value-Added Services sales

for the

quarter decreased 4.8%, on both a reported and internal

sales growth basis,

compared with the third quarter of 2025.

●

Global Specialty Products sales

for the quarter increased 6.1% in total,

reflecting 3.4% internal sales growth,

2.6% sales growth from acquisitions, and a 0.1% increase resulting

from foreign currency exchange,

compared

with the third quarter of 2025.

●

Global Technology sales

for the quarter increased 5.2%

in total,

reflecting 6.5% internal sales growth, 1.3% sales

decrease due to a business disposal,

and no impact from foreign currency exchange,

compared with the third quarter

of 2025.

●

GAAP net income

2

for the quarter was $119 million. GAAP diluted earnings per share were $1.06 per diluted

share

3

, up 26.2% compared with the third quarter of 2025.

●

Non-GAAP net income

2

for the quarter was $175 million. Non-GAAP diluted earnings per share

were $1.56 per

diluted share, up 13.0% compared with the third quarter of 2025.

●

The Company recognized a $0.19

per diluted share

3,4

net benefit from tariff refunds

in the third quarter of 2026,

and a $0.23 per diluted share

3,4

remeasurement gain

in the third quarter of 2025, included in our GAAP and non-

GAAP results.

●

Excluding these items, non-GAAP diluted EPS was $1.37

4

compared with $1.15

4

in the prior-year period, an

increase of 19.1%.

●

Adjusted EBITDA

5

for the quarter was $321 million, compared

with Adjusted EBITDA for the third quarter 2025

of $295 million, with Adjusted EBITDA margin growing 40 basis points to 9.24%.

Year

-to-Date Financial Results

●

Total

net sales

for the first nine months of 2026 were $10.3 billion, an increase

of 5.6% in total compared to the

first nine months of 2025, reflecting 3.4% internal sales growth, 0.7% sales

growth from acquisitions, and a 1.5%

increase resulting from foreign currency exchange. Year-to-date sales growth is detailed in Exhibit A

1

.

●

GAAP net income

2

for the first nine months of 2026 was $320 million. GAAP diluted earnings per

share were

$2.80 per diluted share

3

, up 15.7% compared

with the first nine months of 2025.

●

Non-GAAP net income

2

for the first nine months of 2026 was $473 million. Non-GAAP

diluted earnings per

share were $4.14

per diluted share

3

, up 14.0% compared

with the first nine months of 2025.

●

Adjusted EBITDA

5

for the first nine months of 2026 was $898 million, compared

with Adjusted EBITDA for

the first nine months of 2025 of $810 million, with Adjusted EBITDA

margin growing 41 basis points to 8.72%.

-3-

more

Share Repurchases

During the third quarter of 2026, the Company repurchased approximately

1.4 million shares of common stock at an

average price of $86.67 per share for a total of $125 million.

For the year-to-date, the Company repurchased approximately 5.7 million shares of common

stock at an average

price of $79.50 per share for a total of $450 million.

At the end of the quarter,

Henry Schein had approximately $330 million authorized and available

for future stock

repurchases.

2026 Financial Guidance

Henry Schein today raised its financial guidance for 2026. Guidance

is for current continuing operations and does not

include the impact of restructuring expenses and related costs, amortization

expense of acquired intangible assets, the

impairment of intangible assets, changes in contingent consideration, select implementation-related

costs supporting value

creation initiatives, and litigation settlements.

This guidance also assumes that foreign currency exchange rates

remain

generally consistent with current levels.

The Company’s FY2026 non-GAAP diluted EPS guidance includes the net benefit from tariff refunds recognized in

the third quarter, targeted and limited growth-investments in the fourth quarter which will contribute to growth

in 2027, and

improved underlying business performance. The updated guidance assumes

no significant tariff refunds or remeasurement

gains for the remainder of 2026. The changes to the Company’s financial guidance are summarized below:

Updated

Prior

Guidance

Guidance

2026 non-GAAP diluted EPS

3

$5.50 to $5.56

$5.29 to $5.39

2026 total sales growth

4.5% to 5.5%

4.5% to 5.5%

2026 Adjusted EBITDA growth

High-single-

Mid to high-

digits

single-digits

(A) Adjustments to 2026 GAAP Net Income and Diluted EPS

The Company is providing guidance for 2026 diluted EPS and for 2026

Adjusted EBITDA on a non-GAAP basis, as

noted above. The Company is not providing a reconciliation of its 2026 non-GAAP

diluted EPS guidance to its projected

2026 diluted EPS prepared on a GAAP basis, or its 2026 Adjusted EBITDA

guidance to net income prepared on a GAAP

basis. This is because the Company is unable to provide without

unreasonable effort an estimate of restructuring expenses

and related or similar costs, including its ongoing value creation initiatives, and

the corresponding tax effect, which will be

included in the Company’s 2026 diluted EPS and net income, prepared on a GAAP basis. The inability to provide

this

reconciliation is due to the uncertainty and inherent difficulty of predicting the occurrence,

magnitude, financial impact and

timing of related costs.

-4-

more

Management does not believe these items are representative of the Company’s underlying business performance.

For

the same reasons, the Company is unable to address the probable significance

of the unavailable information, which could be

material to future results.

Third-Quarter 2026 Conference Call Webcast

The Company will hold a conference call to discuss third-quarter 2026

financial results today, beginning at 8:00 a.m.

Eastern time. Individual investors are invited to listen to the

conference call through Henry Schein’s website by visiting

https://investor.henryschein.com/webcasts. In addition, a replay will be available beginning shortly after the call has

ended

for a period of one week.

The Company will be posting slides that provide a summary of its third-quarter

2026 financial results on its website

at https://investor.henryschein.com/financials/quarterly-results/

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology

platforms company for healthcare

customers. With approximately 25,000 Team Schein Members worldwide, the Company's network of trusted advisors

provides more than 1 million customers globally with more than 300

valued solutions that help improve operational success

and clinical outcomes. Our Business, Clinical, Technology and Supply Chain solutions help office-based dental and medical

practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental

laboratories, government and institutional health care clinics, as well as

other alternate care sites.

Henry Schein operates through a centralized and automated distribution

network, with a selection of more than

300,000 branded products and Henry Schein corporate brand products

in our main distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville,

N.Y.,

and has operations or affiliates in 34 countries and territories. The Company's sales

reached $13.2 billion in 2025, and

have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public

company in 1995.

For more information, visit Henry Schein at www.henryschein.com.

Cautionary Note Regarding Forward-Looking Statements and Use

of Non-GAAP Financial Information

In accordance with the “Safe Harbor” provisions of the Private Securities Litigation

Reform Act of 1995, we provide the

following cautionary remarks regarding important factors that, among others,

could cause future results to differ materially from the

forward-looking statements, expectations and assumptions expressed or implied herein.

All forward-looking statements made by us are

subject to risks and uncertainties and are not guarantees of future performance.

These forward-looking statements involve known and

unknown risks, uncertainties and other factors that may cause our actual

results, performance and achievements or industry results to be

materially different from any future results, performance or achievements

expressed or implied by such forward-looking statements.

These statements include total sales growth, EPS and Adjusted EBITDA guidance

and statements about our business

expectations, and are generally identified by the use of such terms as “may,”

“could,” “expect,” “intend,” “believe,” “plan,” “estimate,”

“forecast,” “project,” “anticipate,” “to be,” “to make”,

or other comparable terms.

A fuller discussion of our operations, financial

condition and status of litigation matters, including factors that may affect

our business and future prospects, is contained in documents

we file with the United States Securities and Exchange Commission, or SEC, including

our Annual Report on Form 10-K, and will be

contained in subsequent periodic filings we make with the SEC. These documents

identify in detail important risk factors that could cause

our actual performance to differ materially from current

expectations.

-5-

more

Risk factors and uncertainties that could cause actual results to differ

materially from current and historical results include, but

are not limited to: our dependence on third parties for the manufacture and

supply of our products and where we manufacture products,

our dependence on third parties for raw materials or purchased components;

risks relating to the achievement of our strategic growth

objectives, including anticipated results of restructuring and value creation

initiatives; risks related to the Strategic Partnership Agreement

with KKR Hawaii Aggregator L.P.

entered into in January 2025; transitions in senior company leadership

(including, without limitation,

our Chief Executive Officer,

Chief Financial Officer, and

other executive officers); our ability to develop or acquire and

maintain and

protect new products (particularly technology and specialty products)

and services and utilize new technologies that achieve market

acceptance with acceptable margins; transitional challenges

associated with acquisitions and joint ventures, including the failure to

achieve anticipated synergies/benefits, as well as significant

demands on our operations, information systems, legal, regulatory,

compliance, financial and human resources functions in connection

with acquisitions, dispositions and joint ventures; certain provisions in

our governing documents that may discourage third-party acquisitions of

us; adverse changes in supplier rebates or other purchasing

incentives; risks related to the sale of corporate brand products; risks related to activist

investors; security risks associated with our

information systems and technology products and services, such as cyberattacks

or other privacy or data security breaches (including the

October 2023 incident); effects of a highly competitive (including,

without limitation, competition from third-party online commerce

sites) and consolidating market; political, economic, and regulatory

influences on the health care industry; risks from expansion of

customer purchasing power and multi-tiered costing structures; increases in

shipping costs for our products or other service issues with

our third-party shippers, and increases in fuel and energy

costs; changes in laws and policies governing manufacturing, development and

investment in territories and countries where we do business; general global and domestic

macro-economic and political conditions,

including inflation, deflation, recession, unemployment (and

corresponding increase in under-insured populations),

consumer confidence,

sovereign debt levels, fluctuations in energy pricing and

the value of the U.S. dollar as compared to foreign currencies and changes to

other economic indicators;

failure to comply with existing and future regulatory requirements, including

relating to health care; risks

associated with the EU Medical Device Regulation; failure to comply with

laws and regulations relating to health care fraud or other laws

and regulations; failure to comply with laws and regulations relating to the

collection, storage and processing of sensitive personal

information or standards in electronic health records or transmissions; changes

in tax legislation, changes in tax rates and availability of

certain tax deductions; risks related to product liability,

intellectual property and other claims; risks associated with customs policies or

legislative import restrictions; risks associated with disease outbreaks,

epidemics, pandemics (such as the COVID-19 pandemic), or

similar wide-spread public health concerns and other natural or man-made disasters; risks

associated with our global operations; the threat

or outbreak of war (including, without limitation, geopolitical wars),

terrorism or public unrest (including, without limitation, the wars in

Ukraine and Iran,

the Israel-Gaza conflict and other unrest and threats in the Middle East and the possibility of

a wider European or global

conflict); changes to laws and policies governing foreign trade, tariffs

and sanctions or greater restrictions on imports and exports,

including changes to international trade agreements and the current

imposition of (and the potential for additional) tariffs by the U.S. on

numerous countries and retaliatory tariffs; supply chain disruption;

litigation risks; new or unanticipated litigation developments and the

status of litigation matters; our dependence on our senior management,

employee hiring and retention, increases in labor costs or health

care costs, and our relationships with customers, suppliers and manufacturers; and

disruptions in financial markets. The order in which

these factors appear should not be construed to indicate their relative importance

or priority.

We caution that

these factors may not be exhaustive and that many of these factors are beyond our

ability to control or predict.

Accordingly, any forward-looking

statements contained herein should not be relied upon as a prediction of actual

results. We undertake

no duty and have no obligation to update forward-looking statements except

as required by law.

Included within the press release are non-GAAP financial measures that supplement

the Company’s Consolidated Statements of

Income prepared under generally accepted accounting principles (GAAP).

These non-GAAP financial measures adjust the Company’s

actual results prepared under GAAP to exclude certain items. In the schedule

attached to the press release, the non-GAAP measures have

been reconciled to and should be considered together with the Consolidated

Statements of Income. Management believes that non-GAAP

financial measures provide investors with useful supplemental information

about the financial performance of our business, enable

comparison of financial results between periods where certain items may vary independent

of business performance and allow for greater

transparency with respect to key metrics used by management in operating

our business. The impact of certain items that are excluded

include integration and restructuring costs, amortization of acquisition-related

assets, the insurance claim recovery associated with the

cybersecurity incident, changes in contingent consideration, costs associated with shareholder

advisory matters and select value creation

consulting costs, and litigation settlements because the amount and

timing of such charges are significantly impacted by the timing, size,

number and nature of the acquisitions we consummate and occur on an

unpredictable basis. These non-GAAP financial measures are

presented solely for informational and comparative purposes and should

not be regarded as a replacement for corresponding, similarly

captioned, GAAP measures.

1

See Exhibit A for details of sales growth. Internal sales growth is calculated

from total net sales using constant foreign

currency exchange rates and excludes sales from acquisitions.

2

See Exhibit B for a reconciliation of GAAP net income and diluted

EPS to non-GAAP net income and diluted EPS.

3

References to diluted EPS refer to diluted EPS attributable to Henry Schein, Inc.

4

See Exhibit D for a summary of Net Acquisition Related Fair Value Adjustments and Net Tariff Refunds

5

See Exhibit C for a reconciliation of GAAP net income to Adjusted EBITDA.

-6-

more

CONTACTS:

Investors

Ronald N. South

Senior Vice President and Chief Financial Officer

[email protected]

(631) 843-5500

Graham Stanley

Vice President, Investor Relations and Strategic Financial Project Officer

[email protected]

(631) 843-5500

Media

Tim Vassilakos

Vice President,

Global Corporate Communications

[email protected]

(516) 510-0926

(TABLES TO FOLLOW)

-7-

more

HENRY SCHEIN, INC.

CONDENSED CONSOLIDATED

STATEMENTS

OF INCOME

(in millions,

except share and per share data)

(unaudited)

Three Months Ended

Nine Months Ended

September 26,

September 27,

September 26,

September 27,

2026

2025

2026

2025

Net sales

$

3,471

$

3,339

$

10,297

$

9,747

Cost of sales

2,366

2,313

7,021

6,705

Gross profit

1,105

1,026

3,276

3,042

Operating expenses:

Selling, general and administrative

819

760

2,459

2,276

Depreciation and amortization

71

68

208

194

Restructuring and related costs

22

34

63

82

Operating income

193

164

546

490

Other income (expense):

Interest income

9

9

24

24

Interest expense

(42)

(38)

(124)

(111)

Other, net

-

(1)

1

(3)

Income before taxes, equity in earnings of affiliates and

noncontrolling interests

160

134

447

400

Income taxes

(37)

(28)

(109)

(94)

Equity in earnings of affiliates, net of tax

3

3

2

10

Net income

126

109

340

316

Less: Net income attributable to noncontrolling interests

(7)

(8)

(20)

(19)

Net income attributable to Henry Schein, Inc.

$

119

$

101

$

320

$

297

Earnings per share attributable to Henry Schein, Inc.:

Basic

$

1.07

$

0.84

$

2.83

$

2.44

Diluted

$

1.06

$

0.84

$

2.80

$

2.42

Weighted-average common

shares outstanding:

Basic

111,272,868

120,199,552

113,220,442

121,965,991

Diluted

112,538,936

121,036,247

114,338,114

122,840,062

-8-

more

HENRY SCHEIN, INC.

CONDENSED CONSOLIDATED

BALANCE SHEETS

(in millions, except share data)

September 26,

December 27,

2026

2025

(unaudited)

ASSETS

Current assets:

Cash and cash equivalents

$

184

$

156

Accounts receivable, net of allowance for credit losses of $103 and $90

1,875

1,651

Inventories, net

2,050

2,002

Prepaid expenses and other

667

655

Total current assets

4,776

4,464

Property and equipment, net

619

621

Operating lease right-of-use assets

336

301

Goodwill

4,270

4,213

Other intangibles, net

921

1,018

Investments and other

588

598

Total assets

$

11,510

$

11,215

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND

STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

1,203

$

1,154

Bank credit lines

1,000

764

Current maturities of long-term debt

142

33

Operating lease liabilities

79

78

Accrued expenses:

Payroll and related

325

340

Taxes

191

179

Other

658

680

Total current liabilities

3,598

3,228

Long-term debt

2,382

2,310

Deferred income taxes

152

146

Operating lease liabilities

288

251

Other liabilities

359

486

Total liabilities

6,779

6,421

Redeemable noncontrolling interests

914

895

Commitments and contingencies

Stockholders' equity:

Preferred stock, $0.01 par value, 1,000,000 shares authorized,

none outstanding

-

-

Common stock, $0.01 par value, 480,000,000 shares authorized,

110,538,632 issued and outstanding on September 26, 2026 and

115,771,149 issued and outstanding on December 27, 2025

1

1

Additional paid-in capital

140

177

Retained earnings

3,205

3,293

Accumulated other comprehensive loss

(187)

(226)

Total Henry Schein, Inc. stockholders' equity

3,159

3,245

Noncontrolling interests

658

654

Total stockholders' equity

3,817

3,899

Total liabilities, redeemable noncontrolling

interests and stockholders' equity

$

11,510

$

11,215

-9-

more

HENRY SCHEIN, INC.

CONDENSED CONSOLIDATED

STATEMENTS

OF CASH FLOWS

(in millions)/(unaudited)

Three Months Ended

Nine Months Ended

September 26,

September 27,

September 26,

September 27,

2026

2025

2026

2025

Cash flows from operating activities:

Net income

$

126

$

109

$

340

$

316

Adjustments to reconcile net income to net cash

provided by operating activities:

Depreciation and amortization

86

80

251

229

Impairment charge on intangible assets

-

-

-

1

Non-cash restructuring charges

-

4

4

7

Stock-based compensation expense

10

13

26

29

Provision for losses on trade and other accounts receivable

8

4

16

9

Provision for (benefit from) deferred income taxes

6

7

(2)

-

Equity in earnings of affiliates

(3)

(3)

(2)

(10)

Distributions from equity affiliates

2

1

6

9

Changes in unrecognized tax benefits

(13)

7

(17)

6

Other

(5)

(13)

(26)

(44)

Changes in operating assets and liabilities, net of acquisitions:

Accounts receivable

(122)

(98)

(238)

(198)

Inventories

8

4

(41)

(25)

Other current assets

(31)

(40)

(21)

(3)

Accounts payable and accrued expenses

89

99

10

5

Net cash provided by operating activities

161

174

306

331

Cash flows from investing activities:

Purchases of property and equipment

(30)

(33)

(85)

(96)

Payments related to equity investments and business acquisitions,

net of cash acquired

-

(11)

(30)

(112)

Proceeds from loan to affiliate

1

-

3

2

Capitalized software costs

(15)

(12)

(45)

(38)

Other

(1)

-

(16)

(9)

Net cash used in investing activities

(45)

(56)

(173)

(253)

Cash flows from financing activities:

Net change in bank credit lines

(24)

9

237

257

Proceeds from issuance of long-term debt

95

70

239

314

Principal payments for long-term debt

(10)

(7)

(60)

(28)

Debt issuance costs

(3)

-

(3)

(2)

Proceeds from issuance of stock upon exercise of stock options

2

-

4

1

Payments for repurchases and retirement of common stock

(125)

(203)

(450)

(650)

Issuance of common stock

-

-

-

250

Payments for taxes related to shares withheld for employee taxes

(3)

-

(15)

(14)

Proceeds from (distributions to) noncontrolling shareholders

(22)

6

(44)

(12)

Payments for contingent consideration

-

-

(4)

(19)

Acquisitions of noncontrolling interests in subsidiaries

-

(2)

(42)

(79)

Net cash provided by (used in) financing activities

(90)

(127)

(138)

18

Effect of exchange rate changes on cash and cash equivalents

1

-

33

(82)

Net change in cash and cash equivalents

27

(9)

28

14

Cash and cash equivalents, beginning of period

157

145

156

122

Cash and cash equivalents, end of period

$

184

$

136

$

184

$

136

-10-

more

Exhibit A - Third Quarter Sales

Henry Schein, Inc.

2026 Third Quarter

Sales Summary

(in millions)

(unaudited)

Q3 2026 over Q3 2025

Constant Currency

Growth

Q3 2026

Q3 2025

Local

Internal

Growth

Acquisition

/(Disposition)

Growth

Total

Constant

Currency

Growth

Foreign

Exchange

Impact

Total Sales

Growth

U.S. Distribution and Value-Added

Services

Merchandise

$

660

$

607

7.0%

1.6%

8.6%

0.0%

8.6%

Equipment

220

217

1.6%

0.0%

1.6%

0.0%

1.6%

Value-Added Services

53

57

-7.6%

0.0%

-7.6%

0.0%

-7.6%

Total Dental

933

881

4.7%

1.2%

5.9%

0.0%

5.9%

Medical

1,110

1,099

1.0%

0.0%

1.0%

0.0%

1.0%

Total U.S. Distribution and Value-Added

Services

2,043

1,980

2.6%

0.6%

3.2%

0.0%

3.2%

International Distribution and Value-

Added Services

Merchandise

635

603

3.3%

0.9%

4.2%

1.2%

5.4%

Equipment

229

223

3.2%

0.0%

3.2%

-0.3%

2.9%

Value-Added Services

9

7

15.7%

0.0%

15.7%

0.7%

16.4%

Total Dental

873

833

3.4%

0.7%

4.1%

0.8%

4.9%

Medical

28

27

2.0%

0.0%

2.0%

2.2%

4.2%

Total International Distribution and

Value-Added Services

901

860

3.3%

0.7%

4.0%

0.8%

4.8%

Global Distribution and Value-Added

Services

Global Merchandise

1,295

1,210

5.1%

1.3%

6.4%

0.6%

7.0%

Global Equipment

449

440

2.4%

0.0%

2.4%

-0.1%

2.3%

Global Value-Added Services

62

64

-4.8%

0.0%

-4.8%

0.0%

-4.8%

Global Dental

1,806

1,714

4.1%

0.9%

5.0%

0.4%

5.4%

Global Medical

1,138

1,126

1.0%

0.0%

1.0%

0.1%

1.1%

Total Global Distribution and Value-

Added Services

2,944

2,840

2.9%

0.5%

3.4%

0.3%

3.7%

Global Specialty Products

391

369

3.4%

2.6%

6.0%

0.1%

6.1%

Global Technology

181

173

6.5%

-1.3%

5.2%

0.0%

5.2%

Eliminations

(45)

(43)

n/a

n/a

n/a

n/a

n/a

Total Global

$

3,471

$

3,339

3.1%

0.7%

3.8%

0.2%

4.0%

-11-

more

Exhibit A - Year-to-Date Sales

Henry Schein, Inc.

2026 Third Quarter Year-to-Date

Sales Summary

(in millions)

(unaudited)

Q3 2026 Year-to-Date over Q3 2025 Year-to-Date

Constant Currency

Growth

Q3 2026

Q3 2025

Local

Internal

Growth

Acquisition

/(Disposition)

Growth

Total

Constant

Currency

Growth

Foreign

Exchange

Impact

Total Sales

Growth

U.S. Distribution and Value-Added

Services

Merchandise

$

1,936

$

1,800

5.9%

1.6%

7.5%

0.0%

7.5%

Equipment

630

623

1.2%

0.0%

1.2%

0.0%

1.2%

Value-Added Services

152

153

-0.6%

0.0%

-0.6%

0.0%

-0.6%

Total Dental

2,718

2,576

4.4%

1.1%

5.5%

0.0%

5.5%

Medical

3,180

3,117

2.0%

0.0%

2.0%

0.0%

2.0%

Total U.S. Distribution and Value-Added

Services

5,898

5,693

3.1%

0.5%

3.6%

0.0%

3.6%

International Distribution and Value-

Added Services

Merchandise

1,988

1,813

3.5%

1.0%

4.5%

5.2%

9.7%

Equipment

692

640

4.1%

0.0%

4.1%

4.0%

8.1%

Value-Added Services

28

21

18.1%

4.9%

23.0%

5.9%

28.9%

Total Dental

2,708

2,474

3.8%

0.7%

4.5%

4.9%

9.4%

Medical

88

80

4.1%

0.0%

4.1%

6.4%

10.5%

Total International Distribution and

Value-Added Services

2,796

2,554

3.8%

0.7%

4.5%

5.0%

9.5%

Global Distribution and Value-Added

Services

Global Merchandise

3,924

3,613

4.7%

1.3%

6.0%

2.6%

8.6%

Global Equipment

1,322

1,263

2.7%

0.0%

2.7%

2.0%

4.7%

Global Value-Added Services

180

174

1.8%

0.6%

2.4%

0.7%

3.1%

Global Dental

5,426

5,050

4.1%

0.9%

5.0%

2.4%

7.4%

Global Medical

3,268

3,197

2.0%

0.1%

2.1%

0.1%

2.2%

Total Global Distribution and Value-

Added Services

8,694

8,247

3.3%

0.6%

3.9%

1.5%

5.4%

Global Specialty Products

1,207

1,122

2.6%

2.7%

5.3%

2.3%

7.6%

Global Technology

535

502

7.5%

-1.3%

6.2%

0.6%

6.8%

Eliminations

(139)

(124)

n/a

n/a

n/a

n/a

n/a

Total Global

$

10,297

$

9,747

3.4%

0.7%

4.1%

1.5%

5.6%

-12-

more

Exhibit B

Henry Schein, Inc.

2026 Third Quarter and Year

-to-Date

Reconciliation of reported GAAP net income and diluted EPS attributable to Henry Schein, Inc.

to non-GAAP net income and diluted EPS attributable to Henry Schein, Inc.

(in millions, except per share data)

(unaudited)

Third Quarter

Year-to-Date

%

%

2026

2025

Growth

2026

2025

Growth

Net income attributable to Henry Schein, Inc.

$

119

$

101

17.1

%

$

320

$

297

7.6

%

Diluted EPS attributable to Henry Schein, Inc.

$

1.06

$

0.84

26.2

%

$

2.80

$

2.42

15.7

%

Non-GAAP Adjustments, net of tax and attribution to

noncontrolling interests

Restructuring and related costs (1)

$

16

$

25

$

44

$

58

Acquisition intangible amortization (2)

26

27

81

81

Cyber incident-insurance proceeds, net of third-party advisory

expenses (3)

-

-

-

(15)

Change in contingent consideration (4)

-

5

-

3

Costs associated with shareholder advisory matters and select

implementation related value creation consulting costs (5)

14

7

28

18

Litigation settlements (6)

-

1

-

2

Impairment of intangible assets (7)

-

-

-

1

Non-GAAP adjustments to net income

$

56

$

65

$

153

$

148

Non-GAAP net income attributable to Henry Schein, Inc.

$

175

$

167

4.7

%

$

473

$

445

6.2

%

Non-GAAP diluted EPS attributable to Henry Schein, Inc.

$

1.56

$

1.38

13.0

%

$

4.14

$

3.63

14.0

%

Management believes that non-GAAP financial measures

provide investors with useful supplemental information

about the financial

performance of our business, enable comparison of financial results

between periods where certain items may

vary independent of

business performance and allow for greater transparency

with respect to key metrics used by management

in operating our business.

These non-GAAP financial measures are

presented solely for informational and comparative

purposes and should not be regarded

as a

replacement for corresponding,

similarly captioned, GAAP measures.

Net income growth rates are

based on actual values and may not

recalculate due to rounding.

Amounts may not sum due to rounding.

(1)

Restructuring and Related Costs

The following table presents details of our restructuring and related costs:

Third Quarter

Year

-to-Date

2026

2025

2026

2025

Restructuring and related costs - pre-tax, as reported

$

22

$

34

$

63

$

82

Income tax benefit

(5)

(9)

(15)

(21)

Amount attributable to noncontrolling interests

(1)

-

(4)

(3)

Restructuring and related costs, net

$

16

$

25

$

44

$

58

-13-

more

(2)

Acquisition Intangible Amortization

The following table presents details of amortization of acquired intangible

assets:

Third Quarter

Year

-to-Date

2026

2025

2026

2025

Acquisition intangible amortization - pre-tax, as reported

$

44

$

46

$

135

$

133

Income tax benefit

(11)

(12)

(34)

(33)

Amount attributable to noncontrolling interests

(7)

(7)

(20)

(19)

Acquisition intangible amortization, net

$

26

$

27

$

81

$

81

(3)

Represents cyber insurance proceeds, net of one time professional and

other fees related to remediation of our Q4 2023

cyber incident.

During Q1 2025, we received insurance proceeds of $20 million ($15 million, net of

taxes) under this

policy representing the remaining insurance recovery of losses related

to the cyber incident.

(4)

Represents a change in the fair value of contingent consideration of $1 million ($0

million, net of taxes) and $0 million

($0 million, net of taxes) recorded during Q3 2026 and YTD 2026, respectively,

and $7 million ($5 million, net of

taxes) and $5 million ($3 million, net of taxes) recorded during Q3 2025 and

YTD 2025, respectively, related

to certain

2023, 2024 and 2025 acquisitions.

(5)

Represents costs associated with shareholder advisory matters and select value

creation consulting costs of $18 million

($14 million, net of taxes) and $37 million ($28 million, net of taxes) recorded

during Q3 2026 and YTD 2026,

respectively, and $10 million

($7 million, net of taxes) and $24 million ($18 million, net of taxes) recorded during Q3

2025 and YTD 2025, respectively.

(6)

Represents settlement amounts for litigation related to certain opioid related

lawsuits during Q3 2025 and YTD 2025

and a settlement at one of our businesses.

(7)

Represents impairment charges recorded in Q1 2025 on

certain intangible assets.

-14-

more

Exhibit C

Henry Schein, Inc.

2026 Third Quarter and Year

-to-Date

Reconciliation of reported GAAP net income to Adjusted EBITDA

(in millions)

(unaudited)

Third Quarter

Year-to-Date

2026

2025

2026

2025

Net income attributable to Henry Schein, Inc. (GAAP)

$

119

$

101

$

320

$

297

Net income attributable to noncontrolling interests

7

8

20

19

Net income (GAAP)

126

109

340

316

Definitional adjustments:

Interest income

(9)

(9)

(24)

(24)

Interest expense

42

38

124

111

Income taxes

37

28

109

94

Depreciation and amortization

86

80

250

229

Non-GAAP adjustments:

Restructuring and related costs

22

34

63

82

Cyber incident-insurance proceeds, net of third-party advisory

expenses

-

-

-

(20)

Impairment of intangible assets

-

-

-

1

Change in contingent consideration

1

6

-

4

Costs associated with shareholder advisory matters and select

implementation related value

creation consulting costs

18

10

37

24

Litigation settlements

1

2

1

3

Other adjustments:

Equity in earnings of affiliates, net of tax

(3)

(3)

(2)

(10)

Adjusted EBITDA (non-GAAP)

$

321

$

295

$

898

$

810

Adjusted EBITDA is a non-GAAP measure that we calculate in the manner reflected

on Exhibit C.

We define Adjusted

EBITDA as net

income, excluding (i) net income attributable to noncontrolling interests, (ii)

interest income and expense, (iii) income taxes, (iv)

depreciation and amortization, (v) restructuring and related costs, (vi) cyber

incident-insurance proceeds, net of third-party advisory

expenses, (vii) impairment of intangible assets, (viii) change in contingent

consideration, (ix) costs associated with shareholder advisory

matters and select implementation related value creation consulting costs,

(x) litigation settlements, and (xi) equity in earnings of

affiliates, net of tax.

Amounts may not sum due to rounding.

-15-

###

Exhibit D

Henry Schein, Inc.

2026 Third Quarter and Year

-to-Date

Impact of Net Tariff Refunds and Remeasurement

Gains on Earnings Per Share

(unaudited)

Third Quarter

Year

-to-Date

2026

2025

Growth

2026

2025

Growth

GAAP diluted EPS attributable to Henry Schein, Inc.

$

1.06

$

0.84

26.2%

$

2.80

$

2.42

15.7%

Non-GAAP adjustments (1)

0.50

0.54

1.34

1.21

Non-GAAP diluted EPS attributable to Henry Schein, Inc.

1.56

1.38

13.0%

4.14

3.63

14.0%

Net tariff refunds benefit, net of tax (2)

(0.19)

-

(0.20)

-

Remeasurement gains, net of tax (3)

-

(0.23)

(0.07)

(0.26)

Adjusted non-GAAP diluted EPS attributable to Henry

Schein, Inc.

$

1.37

$

1.15

19.1%

$

3.87

$

3.37

14.8%

Management presents adjusted non-GAAP diluted EPS excluding net tariff refund benefits and remeasurement gains as we believe

this presentation facilitates

comparison of the Company's underlying operating performance

between periods.

(1) See Exhibit B for adjustments reconciling GAAP

diluted EPS attributable to Henry Schein, Inc. to non-GAAP

diluted EPS attributable to Henry Schein,

Inc.

(2) Represents the net benefit, net of tax, from the International

Emergency Economic Powers Act (IEEPA) tariff refunds recognized during the period.

(3) Represents the benefits, net of tax, related to remeasurement

to the fair value of previously held equity investments.

Vlastní portfolio, nemovitosti a finance na jednom místě.

Účet je zdarma a bez časového omezení. Vaše data vidíte jen vy, nikdo je nesčítá s ostatními.

Tohle se ukládá k účtu. Prohlížet, počítat a porovnávat můžete dál bez přihlášení.

Vítejte zpět

Přihlaste se a pokračujte tam, kde jste skončili.

nebo pokračujte přes

Nemáte účet? Vytvořit účet zdarma